The purpose of this training program is to provide education in the pharmacological sciences and to train students in the philosophies, strategies and techniques of modern biological research. Graduates of this program in the past have obtained postdoctoral research experiences and then taken positions at universities, government laboratories or industrial research laboratories. There are 25 faculty associated with the program and thirty five students currently in the graduate program in pharmacological sciences. When a student has completed the requirements for the PhD degree, he or she will: 1. Have a basic understanding of areas closely allied to pharmacological sciences including physiology, molecular biology and biochemistry. 2. Have a broad background knowledge in pharmacological sciences. 3. Possess advanced knowledge in the specialty of the pharmacological sciences concerned with his or her dissertation research. 4. Have demonstrated the ability to design and perform research of high quality and communicate the results to others in a lucid manner. The program is characterized by the size and excellence of its faculty, the breadth and depth of research training opportunities and an exceptionally rich environment for education and research in the biological sciences.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007324-35
Application #
8102810
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
1975-07-01
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
35
Fiscal Year
2011
Total Cost
$162,835
Indirect Cost
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Huet-Calderwood, Clotilde; Rivera-Molina, Felix; Iwamoto, Daniel V et al. (2017) Novel ecto-tagged integrins reveal their trafficking in live cells. Nat Commun 8:570
Mo, Elizabeth S; Cheng, Qianni; Reshetnyak, Andrey V et al. (2017) Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk. Proc Natl Acad Sci U S A 114:12027-12032
Bauer, Ashley J; Martin, Kathleen A (2017) Coordinating Regulation of Gene Expression in Cardiovascular Disease: Interactions between Chromatin Modifiers and Transcription Factors. Front Cardiovasc Med 4:19
Grabi?ska, Kariona A; Edani, Ban H; Park, Eon Joo et al. (2017) A conserved C-terminal RXG motif in the NgBR subunit of cis-prenyltransferase is critical for prenyltransferase activity. J Biol Chem 292:17351-17361
Smithy, James W; Moore, Lauren M; Pelekanou, Vasiliki et al. (2017) Nuclear IRF-1 expression as a mechanism to assess ""Capability"" to express PD-L1 and response to PD-1 therapy in metastatic melanoma. J Immunother Cancer 5:25
Panaccione, Alex; Zhang, Yi; Ryan, Molly et al. (2017) MYB fusions and CD markers as tools for authentication and purification of cancer stem cells from salivary adenoid cystic carcinoma. Stem Cell Res 21:160-166
Langdon, Casey G; Platt, James T; Means, Robert E et al. (2017) Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor. Mol Cancer Ther 16:1041-1053
Puleo, David E; Kucera, Kaury; Hammarén, Henrik M et al. (2017) Identification and Characterization of JAK2 Pseudokinase Domain Small Molecule Binders. ACS Med Chem Lett 8:618-621
Moore, Lauren M; England, Allison; Ehrlich, Barbara E et al. (2017) Calcium Sensor, NCS-1, Promotes Tumor Aggressiveness and Predicts Patient Survival. Mol Cancer Res 15:942-952
Wali, Vikram B; Langdon, Casey G; Held, Matthew A et al. (2017) Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer. Cancer Res 77:566-578

Showing the most recent 10 out of 65 publications